Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating.
Carson
Kenneth R
KR
Siteman Comprehensive Cancer Center, Washington University School of Medicine, Saint Louis, MO 63110, USA. kcarson@dom.wustl.edu
Bennett
Charles L
CL
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy* / Q000276:immunology; D018570:Risk Assessment; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab